H1B Report
Side-by-side comparison

COGNIZANT TECHNOLOGY SOLUTIONS US CORP vs Novo Nordisk, Inc.

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
COGNIZANT TECHNOLOGY SOLUTIONS US CORP
TXRank #3FEIN 13-3924155
Entity B
Novo Nordisk, Inc.
NJRank #FEIN 06-1061602

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricCOGNIZANT TECHNOLOGY SOLUTIONS US CORPNovo Nordisk, Inc.
Total filings125,757114
Certified %96.07%83.33%
Denied %0.28%1.75%
Withdrawn %2.28%4.39%
Cert-withdrawn %1.37%10.53%
Rank#3
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateTXNJ

Outcomes — COGNIZANT TECHNOLOGY SOLUTIONS US CORP

DOL case-status mix.

Outcome breakdown: Certified 96.1%, Cert-withdrawn 1.4%, Withdrawn 2.3%, Denied 0.3%
Outcome breakdown
OutcomeShare
Certified96.1%
Cert-withdrawn1.4%
Withdrawn2.3%
Denied0.3%
Certified96.1%
Cert-withdrawn1.4%
Withdrawn2.3%
Denied0.3%

Outcomes — Novo Nordisk, Inc.

DOL case-status mix.

Outcome breakdown: Certified 83.3%, Cert-withdrawn 10.5%, Withdrawn 4.4%, Denied 1.8%
Outcome breakdown
OutcomeShare
Certified83.3%
Cert-withdrawn10.5%
Withdrawn4.4%
Denied1.8%
Certified83.3%
Cert-withdrawn10.5%
Withdrawn4.4%
Denied1.8%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

COGNIZANT TECHNOLOGY SOLUTIONS US CORP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20101,454
FY20112,735
FY20121,696
FY20131,543
FY20142,166
FY20153,105
FY20164,378
FY20172,373
FY201812,405
FY201925,248
FY20203,117
FY202110,079
FY202213,705
FY202315,729
FY202411,437
FY202511,140
FY20263,447
Novo Nordisk, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20103
FY20118
FY20125
FY201310
FY20146
FY20157
FY20166
FY20176
FY20184
FY20192
FY20202
FY20218
FY20223
FY20233
FY202417
FY202515
FY20269

Top 5 occupations — COGNIZANT TECHNOLOGY SOLUTIONS US CORP

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.